Linghang Zhuang, PhD

Dr Zhuang joined EBI in May 2017 as the Head of Chemistry and took the responsibility of oversighting several drug discovery programs.

Prior to joining EBI, Linghang was a Director of Chemistry at Vitae Pharmaceuticals Inc., an Allergan affiliate. During the 11 years’ tenue, he led discovery efforts in autoimmune disease, diabetes, cardiovascular disease and oncology areas. He supported development and IND enabling activities and advanced 3 compounds to human clinical trials.

Before joining Vitae, Linghang was a Research Fellow at Merck, working on anti-infectious disease and CNS programs for 7 years.

Over his career, Linghang has co-authored more than 80 scientific papers and patent applications.

Linghang received his Ph.D. in Chemistry from the University of Pennsylvania, under the guidance of Professor Amos B. Smith III and B.S. in chemistry from University of Science and Technology of China.